Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Copper-Coated catheter aims to slash hospital infections

NCT ID NCT07530328

Disease control Sponsor: WMAS SpA Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new type of urinary catheter coated with copper nanoparticles to see if it could lower the risk of urinary tract infections in hospitalized adults. 256 patients who needed a catheter for a long time took part. The goal was to compare this new catheter to standard ones and check if it is both safe and effective at reducing infections.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

256 people

The number who actually took part.

Started

Jan 2024

Finished

Aug 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 100 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years of age). * Hospitalized patients from medical, surgical, emergency, operating room, or intensive care units. * Patients with clinical indication for permanent urinary catheterization (Catéter Urinario Permanente, CUP). * Patients able to provide written informed consent, or consent provided by a legally authorized representative. Exclusion Criteria: * History of urinary tract infection prior to hospitalization within the last month without a post-treatment follow-up urine culture. * Patients with a positive initial urine culture at the time of permanent urinary catheter (CUP) insertion. * Patients with a history of allergy to silicone or to any component of the COPESILCUP device. * Patients unable to complete follow-up, for example, due to transfer to another healthcare facility within the first 72 hours after stabilization. * Patients with psychiatric conditions that may result in non-professional manipulation of the urinary catheter. * Patients with a history of prior urinary tract colonization. * Patients with a history of urinary or renal instrumentation or surgical intervention within the last month. * Patients with pre-existing abnormalities of the pyeloureteral or urinary system.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Catheter associated infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Catheter-Related Infections nosocomial infection urinary tract infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Catheter associated infection

Contacts and locations

Locations

  • WMAS SpA

    Ñuñoa, Santiago Metropolitan, 750000, Chile

More trials for these conditions

Other studies related to the condition(s) this trial covers.